Accordingly, in patients with T2D who are insulin-resistant, the levels of the rate-limiting enzyme of the hexosamine pathway glutamine-fructose-6-phosphate aminotransferase (GFAT) were found to be elevated. The gene discussed is INS; the disease is type 2 diabetes mellitus.